Ramasastry Saira, Insider at Mirum Pharmaceuticals, Inc., sold $219K of MIRM
This page documents an SEC Form 4 insider trading disclosure for $MIRM securities filed with the Securities and Exchange Commission. Section 16 of the Securities Exchange Act of 1934 mandates that corporate officers, directors, and beneficial owners of more than 10% of a company's registered equity securities must report their personal trades within two business days of execution. Insider transactions are closely monitored by market participants because insiders possess firsthand knowledge of company operations, financial condition, and near-term prospects. The transaction details below are drawn directly from the SEC EDGAR filing database and reflect the information as reported.
Transaction Details
| Insider | Ramasastry Saira |
|---|---|
| Title | Insider |
| Company | Mirum Pharmaceuticals, Inc. |
| Ticker | MIRM |
| Transaction Type | Sale |
| Transaction Date | 2026-05-15 |
| Shares Traded | 2,000 |
| Price Per Share | $109.47 |
| Total Value | $219K |
| Filed Date | 2026-05-18 |
| Accession Number | 0001547959-26-000009 |
Ownership Context
| Shares Owned After Transaction | — |
|---|---|
| Ownership Type | Direct |
SEC Filing
Accession: 0001547959-26-000009
Other Insider Trades — MIRM
| Insider | Title | Action | Value | Date |
|---|---|---|---|---|
| Peetz Christopher | CHIEF EXECUTIVE OFFICER | traded | $59K | 2026-08-10 |
| Peetz Christopher | CHIEF EXECUTIVE OFFICER | sold | $1.2M | 2026-08-10 |
| Peetz Christopher | CHIEF EXECUTIVE OFFICER | sold | $597K | 2026-08-10 |
| Peetz Christopher | CHIEF EXECUTIVE OFFICER | sold | $230K | 2026-08-10 |
| Howe Jolanda | SVP, GLOBAL CONTROLLER | sold | $194K | 2026-08-03 |
| Peetz Christopher | CHIEF EXECUTIVE OFFICER | sold | $1.5M | 2026-07-06 |
| Peetz Christopher | CHIEF EXECUTIVE OFFICER | traded | $59K | 2026-07-06 |
| Peetz Christopher | CHIEF EXECUTIVE OFFICER | sold | $512K | 2026-07-06 |
| BJERKHOLT ERIC | CHIEF FINANCIAL OFFICER | sold | $65K | 2026-07-06 |
| Peetz Christopher | CHIEF EXECUTIVE OFFICER | sold | $244K | 2026-07-06 |
Other Trades by Ramasastry Saira
| Ticker | Company | Action | Value | Date |
|---|---|---|---|---|
| MIRM | Mirum Pharmaceuticals, Inc. | traded | — | 2026-06-15 |
| MIRM | Mirum Pharmaceuticals, Inc. | traded | — | 2026-06-15 |
| FTH | Sensei Biotherapeutics, Inc. | traded | — | 2026-06-12 |
| MIRM | Mirum Pharmaceuticals, Inc. | sold | $398K | 2026-06-01 |
| MIRM | Mirum Pharmaceuticals, Inc. | traded | — | 2026-05-29 |
| MIRM | Mirum Pharmaceuticals, Inc. | traded | $47K | 2026-05-15 |
| DAWN | Day One Biopharmaceuticals, Inc. | traded | — | 2026-04-23 |
| DAWN | Day One Biopharmaceuticals, Inc. | traded | — | 2026-04-23 |
| DAWN | Day One Biopharmaceuticals, Inc. | traded | — | 2026-04-23 |
| DAWN | Day One Biopharmaceuticals, Inc. | traded | — | 2026-04-23 |
Full Ticker Profile
View all insider trades, dark pool activity, congressional filings, and the Whisper Score for MIRM — Mirum Pharmaceuticals, Inc. →
Whisper Score — MIRM
Track MIRM insider activity in real time on The Wire →
Get alerts when Ramasastry Saira files new trades — Go Pro →
Data sourced from SEC Form 4 insider trading filings. Transaction details are as reported to the Securities and Exchange Commission. This page does not constitute financial advice. StonkWhisper presents public records — it does not verify or guarantee the accuracy of SEC filings.
Last updated: August 12, 2026 at 07:28 UTC